ÂÜÀòÂÒÂ×

Guy R. De La Rosa, M.D., is the Chief Medical Officer at Curevo Vaccine. He joined Curevo in 2023. Dr. De La Rosa brings over 20 years of clinical experience directing successful development programs across multiple areas in the field of Infectious Diseases. Prior to joining Curevo Vaccine, Dr. De La Rosa worked for Enanta Pharmaceuticals, where he served in roles of increasing seniority, culminating as Executive Medical Director for Infectious Diseases, and leading the clinical development for several assets for RSV, SARS-CoV-2 and HBV. Prior to his tenure at Enanta Pharmaceuticals, Dr. De La Rosa held positions with Abbott, Janssen, and Takeda Pharmaceuticals where he led the development of assets for HIV, HCV, RSV and Dengue Tetravalent Vaccine. He has co-authored and collaborated in more than 60 scientific publications and presentations.